Dialogue Volume 15, Issue 3 2019 - Page 41

PRACTICE PARTNER The team at U of T’s Safer Opioid Prescribing Program: (Back row, left to right) Dr Kate Hodgson, Dr. Kathleen Doukas, Ms. Nancy Bush, (Front row, left to right) Dr. Abhimanyu Sud and Dr. Kirsten Dixon. Missing: Dr. Meera Harris, Dr. Patrick Skalenda. “The goal was to make these very accessible, where people can do them on their own time, at their own pace,” says Dr. Anthony Levin- son, Project Lead and Director of DeLI. The modules take about 1-2 hours on average, and include a lot of multimedia and interactivity. The appeal of e-Learning is obvious, in allowing for so many educational elements and offering convenience. Yet Dr. Levinson says organizations should still be deliberate in creating e-Learning, and users should be discerning in signing up. “The principles of instructional design, whether online or face-to-face, are the most important thing in determining effectiveness,” says Dr. Levinson. Webinars and workshop combine Dr. Sud, who contributed to one of the Mc- Master modules, agrees that sound design and clear objectives should be at the forefront of any CPD, regardless of the format. The University of Toronto’s Safer Opioid Prescribing Program includes a three-part webinar series, followed by an in-person skill development workshop (cpd.utoronto.ca/ opioidprescribing/). The sessions: 1) Assess- ing Chronic Complex Pain; 2) Prescribing Opioids in Chronic Pain; and 3) Addressing Opioid Challenges. While the series is available to all, Dr. Sud wants to reach primary family physicians in rural and remote communities. That’s where there’s disproportionate harm from opioids, and less access to CPD. “We see this as a public health intervention,” he says. Many e-Learning programs are asynchro- nous, i.e. study on your own with no interac- tions with other learners. The University of Toronto program is synchronous, meaning everyone participates at the same time. It cre- ates a community of learning. ISSUE 3, 2019 DIALOGUE 41